Evidence map›Paper›PMID 33012845›Full record

ArticleJournal of optimization theory and applications2020

On the Role of the Objective in the Optimization of Compartmental Models for Biomedical Therapies.

Urszula Ledzewicz, Heinz Schättler

Abstract read
In one paragraph

Article in Journal of optimization theory and applications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Hazard curvature makes within-host variability costly for survival.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Treatment of evolving cancers will require dynamic decision support.Annals of oncology : official journal of the European Society for Medical Oncology · 2023
    Review
  8. Optimal quarantine-related strategies for COVID-19 control models.Studies in applied mathematics (Cambridge, Mass.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Urszula LedzewiczLodz University of Technology, 90-924 Lodz, Poland.ORCID 0000-0002-6447-1958
Heinz SchättlerWashington University, St. Louis, MO 63130 USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We review and discuss results obtained through an application of tools of nonlinear optimal control to biomedical problems. We discuss various aspects of the modeling of the dynamics (such as growth and interaction terms), modeling of treatment (including pharmacometrics of the drugs), and give special attention to the choice of the objective functional to be minimized. Indeed, many properties of optimal solutions are predestined by this choice which often is only made casually using some simple ad hoc heuristics. We discuss means to improve this choice by taking into account the underlying biology of the problem.

Indexed as

Cancer therapiesMathematical modelingOptimal controlPharmacometrics

Identifiers

PMID33012845
PMCPMC7525767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.